BMD and body composition in children and young patients affected by cystic fibrosis

被引:0
|
作者
Bianchi, ML
Romano, G
Saraifoger, S
Costantini, D
Limonta, C
Colombo, C
机构
[1] IRCCS, Ist Auxol Italiano, Bone Metab Unit, Ctr Malattie Metab Ossee, I-20145 Milan, Italy
[2] Univ Milan, IRCCS, Osped Policlin, Dipartimento Pediat,Ctr Reg Fibrosi Cist, Milan, Italy
关键词
BMD; bone mass; body composition; cystic fibrosis; pediatrics;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Longer survival in cystic fibrosis has led to more bone complications. One hundred thirty-six young patients were studied for 12-24 months. Low BMD was found in 66%. Fat mass and lean mass were also reduced. Impaired pulmonary function and total steroid dose had the greatest negative influence on bone. Introduction: Low BMD is reported as a frequent complication in adult patients affected by cystic fibrosis (CF), but the available data are less consistent for younger patients. Materials and Methods: This study was designed to evaluate BMD longitudinally over 12-24 months in a sample of 136 young patients (3-24 years of age) and to investigate its major determinants. BMC and body composition were also evaluated. Results: BMD (expressed as Z score) of spine and of total body was reduced in 66% of patients. The prevalence of low BMD was the same in children, adolescents, and young adults. The main determinants of platelet count puberty, BMD were forced expiratory volume in 1s (FEV1; as an of pulmonary function). (as an index of portal hypertension), and cumulative steroid dose. Changes of FEV1 over time influenced BMD changes. Bone mass, fat mass (FM) and fat-free (lean) mass (FFM) were reduced in CF patients at both total body and subregions (trunk, limbs). Lean mass influenced BMD of. total body and lower limbs, whereas fat mass (and BMI) influenced spine BMD. FEV1 also influenced FFM. Conclusions: Low BMD was present in a significant proportion of CF patients, independent of sex and age. BMD depended oil pulmonary function, steroid dose, and presence of advanced liver disease. Pulmonary function and puberty were the main stimuli for the increase of BMD over time. CIF also altered body composition, and FFM was influenced by pulmonary function.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 50 条
  • [21] Bone mineral and body composition alterations in paediatric cystic fibrosis patients
    Philippe Reix
    Gabriel Bellon
    Pierre Braillon
    Pediatric Radiology, 2010, 40 : 301 - 308
  • [22] Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis
    Moriconi, N
    Kraenzlin, M
    Müller, B
    Keller, U
    Nusbaumer, CPG
    Stöhr, S
    Tamm, M
    Puder, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04): : 1586 - 1590
  • [23] Use Of Ultrasonography In Body Composition Assessment In Cystic Fibrosis And Pediatric Patients
    Boas, Steven R.
    Wolk, Risa L.
    Wood, Lawrence
    Service, Alex
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 32 - 32
  • [24] Bone mineral and body composition alterations in paediatric cystic fibrosis patients
    Reix, Philippe
    Bellon, Gabriel
    Braillon, Pierre
    PEDIATRIC RADIOLOGY, 2010, 40 (03) : 301 - 308
  • [25] Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis
    Stettler, N
    Kwchak, DA
    Boyle, LL
    Propert, KJ
    Scanlin, TF
    Stallings, VA
    Zemel, BS
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 72 (02): : 407 - 413
  • [26] Body composition and pulmonary function in cystic fibrosis
    Sheikh, Saba
    Zemel, Babette S.
    Stallings, Virginia A.
    Rubenstein, Ronald C.
    Kelly, Andrea
    FRONTIERS IN PEDIATRICS, 2014, 2
  • [27] BODY COMPOSITION AND GLUCOSE TOLERANCE IN CYSTIC FIBROSIS
    Sheikh, S.
    Kelly, A.
    Rubenstein, R. C.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 400 - 401
  • [28] The effect of vitamin K supplementation on BMD in children and adolescent with cystic fibrosis
    Nicolaidou, P
    Georgouli, H
    Stavrinadis, I
    Loukou, J
    Papadopoulou, A
    Douros, K
    Gourgiotis, D
    Antoniou, A
    Doudounakis, S
    PEDIATRIC RESEARCH, 2005, 58 (02) : 379 - 379
  • [29] CFTR modulation for young children with cystic fibrosis
    Yammine, Sophie
    Singer, Florian
    Latzin, Philipp
    LANCET RESPIRATORY MEDICINE, 2016, 4 (02): : 84 - 85
  • [30] Prevalence of tracheobronchomalacia in young children with cystic fibrosis
    Poreddy, Srinivas
    Withers, Adelaide
    Cox, Des
    Stick, Stephen
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40